Market Research Logo

Hospital Acquired Infections: Testing Markets

A nosocomial, or hospital-acquired, infection is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at admission are excluded. This type of infection is also known as a hospital-acquired infection (or more generically healthcare-associated infections). The following are among the hospital infections considered in this report:

  • Acinetobacter Baumannii
  • Clostridium Difficile
  • Hospital-Acquired Pneumonia
  • Pseudomonas Aeruginosa
  • Staphylococcus Aureus
  • Tuberculosis
  • Urinary Tract Infections
  • Vancomycin-resistant Enterococcus
  • Ventilator-Associated Pneumonia
This report focuses on testing for nosocomial infections. The major consideration is given to bacterial nosocomial infections because a) they are the most frequent type of infections spread in the hospital setting, and b) the practical aspects of diagnosis and therapy are more meaningful based both on medial considerations and on market considerations. This report Hospital Acquired Infection Testing Markets looks at the market for diagnostics that address the growing nosocomial infection threat. As part of its coverage, the report includes the following information:
  • Market Size Estimate and Growth Forecast for the HAI Diagnostics Market
  • Issues and Trends Affecting Market
  • Common Hospital (nosocomial) Infections
  • Nosocomial Infection Statistics
  • International Hospital Length of Stay Statistics
  • The Role of Molecular Tests vs. Traditional
  • Corporate Profiles of Key Suppliers

Market analysis in this report considers primarily the epidemiological considerations and the sizes patient groups both in the United States and globally, where available. We have accumulated the most recent data available, understanding that virtually no organization does extensive studies on these applications on a regular basis. Many studies are highly localized and may only apply to a community, state or country (more often countries that are not a part of the major markets for nosocomial diagnostic and therapeutic products). In many instances, we have had to draw from broader epidemiologic data, that is, on data that reach outside of the hospital environment in order to try and construct a picture of the nosocomial testing and treatment needs.

The primary focus of this report is on the bacterial form of nosocomial infections, and those with significant impact on the hospital setting and markets. In looking at these infections, we consider the diagnostic and therapeutic technologies that are currently available and attempt to project trends for diagnosing these infections. To some extent, we are limited by the activity of the industries associated with the diagnosis and treatment of these infections. For the most part, these activities are limited and the advanced technologies seen in other areas of medical application are not necessarily present in terms of microbiology.

Companies Profiled in the report include the following:
  • Abbott Laboratories
  • Alere
  • Becton, Dickinson
  • bioMerieux
  • Cephei
  • Gen-Probe
  • Meridian Bioscience, Inc.
  • Qiagen GmbH
  • Roche
  • Siemens AG

The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, research scientists, business development managers and marketing managers.


  • Executive Summary
    • OVERVIEW
      • Table Frequency of the Most Common Nosocomial Infections
    • INFECTION CONTROL SUMMARY
    • SCOPE AND METHODOLOGY
    • TOTAL SIZE AND GROWTH OF THE MARKET
      • Table The World Market for Hospital Infection Testing/Diagnostics 2007-2016
    • ISSUES AND TRENDS AFFECTING MARKET
    • LEADING COMPETITORS
  • Introduction and Industry Trends
    • OVERVIEW
      • Introduction to Pathogens
      • Classification of Antibacterial Organisms
      • Common Hospital (nosocomial) Infections
    • HOSPITAL UNITS AND INFECTION RISKS
      • Burn Units
        • Table Burn Statistics
      • Intensive Care Units
      • Emergency Departments
      • General Infection Statistics
      • Nosocomial Infection Statistics
      • Hospital Length of Stay
        • Table U.S. Hospital Length of Stay, Average by Age Group
        • Table Average International Length of Stay, by Country 2010
      • Populations at Risk for Infection
        • Table World Population at Risk for Serious Bacterial Infections, Secondary to Chronic Diseases by Selected Geographical Region, 2010
    • DEMOGRAPHICS OF THE WORLD
      • Table Estimated World Population by Age and Geographical Region, 2010
      • Life Expectancy
        • Table Average Life Expectancy in Years by Country 1980, 2004 and 2011
    • ECONOMIC TRENDS
      • Table Total Healthcare Expenditures as a Percent of GDP by Country 1990, 2000 and 2010
      • Comparison Between Healthcare Spending and Real Health Outcomes
        • Table Healthcare Spending, Obesity and Life Expectancy, 2011
    • INFECTIONS AND DRUG RESISTANCE
      • Causes of Drug Resistance
      • Drug Resistance in Select Populations
      • Measures for Reducing Resistance
      • Screening Hospitalized patients
    • PREVENTION MEASURES
      • Potential Use of Copper for Reducing Infections
      • Wide Area Disinfection Methods
      • Software for Infection Detection and Control
    • THE AMERICAN RECOVERY AND REINVESTMENT ACT OF 2009
    • U.S. GOVERNMENT'S NATIONAL ACTION PLAN TO PREVENT HEALTHCARE ASSOCIATED INFECTIONS (HAIS)
      • U.S. Statewide Standardized Infection Ratio
        • Table U.S. States Hospital Acquired Infection Standardized Infection Ratio (SIR)
      • State Level Case Study of HAI Admissions and Readmissions
        • Table Pennsylvania State Analysis of HAI Readmissions and Related Costs, 2009
        • Table Pennsylvania State Analysis of HAIs, 2009
      • John T. Mather Memorial Hospital/Cepheid-Case Study
    • MANUFACTURER AND MARKETER TRENDS
      • Trends in Partnerships and Alliances
      • Developers Trends
  • Hospital Infection Testing Products
    • OVERVIEW
      • Methods of Transmission
    • TESTING METHODS
      • Drug-Resistance/Susceptibility Testing
      • Genotypic Methods
    • SPECIFIC NOSOCOMIAL DISEASE TESTING
      • Acinetobacter Baumannii
      • Clostridium Difficile
      • Hospital-Acquired Pneumonia
      • Pseudomonas Aeruginosa
      • Staphylococcus Aureus
      • Tuberculosis
      • Urinary Tract Infections
      • Vancomycin-resistant Enterococcus
      • Ventilator-Associated Pneumonia
        • Table Recent Approvals for Hospital Infection Testing
    • NEW DEVELOPMENTS
      • Table New Developments, Hospital Infection Testing, as of July 2012
  • Market Opportunities for Hospital Infection Testing
    • MARKET CONSIDERATIONS
    • MARKET OVERVIEW
    • TOTAL MARKET SIZE AND FORECAST
      • Table The World Market for Hospital Infection Testing/Diagnostics 2007-2016
      • Hospital Infection Testing Market by Geographical Region
        • Table The World Market for Hospital Infection Testing/Diagnostics Estimated Products Sales by Geographic Region 2007-2016
    • COMPETITIVE ANALYSIS
      • Table The World Market for Hospital Infection Testing/Diagnostics Leading Suppliers' Shares Estimates for 2011
  • Company Profiles
    • INTRODUCTION
    • ABBOTT LABORATORIES
    • ALERE
    • BECTON, DICKINSON
    • BIOMERIEUX
    • CEPHEID
    • GEN-PROBE
    • MERIDIAN BIOSCIENCE, INC.
    • QIAGEN GMBH
    • ROCHE
    • SIEMENS AG
  • List of Major Providers

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report